Target intelligence / Profile preview

Glucoside xylosyltransferase 1 pseudogene 5 (GXYLT1P5)

Target: GXYLT1P5
Molecular classification: Pseudogene

Overview

Glucoside xylosyltransferase 1 pseudogene 5 (GXYLT1P5) is a human pseudogene located on chromosome 9, classified as non-coding with no known protein product. While pseudogenes like GXYLT1P5 do not encode functional proteins, some may be transcribed and exert regulatory effects on their parent genes or related pathways. Expression of certain pseudogenes, including GXYLT1P5, has been observed in high-throughput transcriptomic and eQTL studies, and clusters of pseudogenes may be linked to regulatory genetic variants or act as eQTLs affecting prognosis in cancer. However, GXYLT1P5 itself does not currently have an established biological function, disease association, or evidence for therapeutic targeting.

Other names: GXYLT1P5Glucoside xylosyltransferase 1 pseudogene 5, GXYLT1P5

Biological functions

Other (Pseudogenes are generally considered non-functional at the protein-coding level, though they may participate in gene regulation or transcriptional processes indirectly)

Disease associations

Other (There is no direct evidence for disease involvement from the pseudogene, but some pseudogenes may act in regulatory roles affecting gene expression and have been included in eQTL and prognosis analyses in cancer)

Biomarkers

There is limited indirect evidence for prognostic biomarker roles of certain pseudogenes in specific cancers, including clear cell renal cell carcinoma (ccRCC), but GXYLT1P5 itself is not established as a clinical biomarker

Beyond the preview

Go deeper on Glucoside xylosyltransferase 1 pseudogene 5 (GXYLT1P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucoside xylosyltransferase 1 pseudogene 5 (GXYLT1P5).

Explore the full profile